Q1 2024 · 13F-HR
RA CAPITAL MANAGEMENT, L.P.holdings as filed
Filed 2024-05-15 · accession 0001104659-24-062062
$7.80B
Reported value
75
Positions
2024-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S - ADR | $1.53B | 19.6% | 10,108,400 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $560.4M | 7.19% | 8,203,754 | Common | SOLE |
| 52490G102 | LEGN | LEGEND BIOTECH CORP-ADR | $384.8M | 4.93% | 6,861,097 | Common | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $345.1M | 4.42% | 9,165,652 | Common | SOLE |
| 008064107 | — | AEROVATE THERAPEUTICS INC | $244.4M | 3.13% | 8,263,982 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $231.0M | 2.96% | 5,330,412 | Common | SOLE |
| 30050B101 | EVH | EVOLENT HEALTH INC - A | $188.1M | 2.41% | 5,736,132 | Common | SOLE |
| N62509109 | NAMS | NEWAMSTERDAM PHARMA CO NV | $186.0M | 2.38% | 7,864,000 | Common | SOLE |
| 78349D107 | RXST | RXSIGHT INC | $177.6M | 2.28% | 3,442,825 | Common | SOLE |
| 90240B106 | TYRA | TYRA BIOSCIENCES INC | $170.8M | 2.19% | 10,416,609 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $162.5M | 2.08% | 8,909,091 | Common | SOLE |
| 35104E100 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $160.9M | 2.06% | 5,051,511 | Common | SOLE |
| 09062X103 | BIIB | BIOGEN INC | $159.7M | 2.05% | 740,727 | Common | SOLE |
| 713317105 | PEPG | PEPGEN INC | $157.1M | 2.01% | 10,689,545 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $152.5M | 1.96% | 46,202,425 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $148.6M | 1.91% | 12,766,948 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $140.7M | 1.80% | 4,954,779 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $131.4M | 1.69% | 1,977,901 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $129.0M | 1.65% | 7,809,852 | Common | SOLE |
| 65487U108 | NKTX | NKARTA INC | $116.8M | 1.50% | 10,805,129 | Common | SOLE |
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $112.3M | 1.44% | 18,202,009 | Common | SOLE |
| 82835W108 | SPRY | ARS PHARMACEUTICALS INC | $111.0M | 1.42% | 10,860,977 | Common | SOLE |
| 359616109 | FULC | FULCRUM THERAPEUTICS INC | $109.6M | 1.41% | 11,609,704 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC - ADR | $101.7M | 1.30% | 6,317,990 | Common | SOLE |
| 52635N103 | LENZ | LENZ THERAPEUTICS INC | $93.3M | 1.20% | 4,178,823 | Common | SOLE |
| 45720L107 | INBXUSD | INHIBRX INC | $91.9M | 1.18% | 2,629,837 | Common | SOLE |
| 05370A108 | RNAGBP | AVIDITY BIOSCIENCES INC | $83.8M | 1.07% | 3,282,180 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $79.8M | 1.02% | 1,000,000 | Common | SOLE |
| 54300N103 | — | LONGBOARD PHARMACEUTICALS IN | $71.0M | 0.91% | 3,289,119 | Common | SOLE |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $70.0M | 0.90% | 2,333,000 | Common | SOLE |
| G3855L106 | GHRS | GH RESEARCH PLC | $66.6M | 0.85% | 6,251,714 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $64.7M | 0.83% | 1,510,362 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $62.6M | 0.80% | 4,850,984 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $62.1M | 0.80% | 4,413,150 | Common | SOLE |
| 00509G209 | ABOS | ACUMEN PHARMACEUTICALS INC | $60.5M | 0.78% | 14,932,063 | Common | SOLE |
| 46565G104 | 5E7 | ITEOS THERAPEUTICS INC | $60.3M | 0.77% | 4,417,259 | Common | SOLE |
| 83422E204 | SLDB | SOLID BIOSCIENCES INC | $57.7M | 0.74% | 4,330,446 | Common | SOLE |
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS INC | $54.6M | 0.70% | 204,500 | Common | SOLE |
| 929033108 | — | VOR BIOPHARMA INC | $53.9M | 0.69% | 22,748,880 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $50.5M | 0.65% | 828,380 | Common | SOLE |
| M96088105 | URGN | UROGEN PHARMA LTD | $46.3M | 0.59% | 3,083,430 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $45.9M | 0.59% | 6,045,351 | Common | SOLE |
| 23285D109 | CTKB | CYTEK BIOSCIENCES INC | $45.7M | 0.59% | 6,809,404 | Common | SOLE |
| 12529R107 | CCCC | C4 THERAPEUTICS INC | $39.9M | 0.51% | 4,878,000 | Common | SOLE |
| 95075A107 | HOWL | WEREWOLF THERAPEUTICS INC | $39.8M | 0.51% | 6,144,881 | Common | SOLE |
| 29337E102 | ELVN | ENLIVEN THERAPEUTICS INC | $37.3M | 0.48% | 2,122,465 | Common | SOLE |
| 28658R106 | CLYM | ELIEM THERAPEUTICS INC | $36.0M | 0.46% | 13,150,849 | Common | SOLE |
| 004890109 | ACRV | ACRIVON THERAPEUTICS INC | $34.4M | 0.44% | 4,810,508 | Common | SOLE |
| 877619106 | TSHA | TAYSHA GENE THERAPIES INC | $31.2M | 0.40% | 10,872,503 | Common | SOLE |
| 10170A100 | BOLD | BOUNDLESS BIO INC | $31.1M | 0.40% | 2,180,631 | Common | SOLE |
| 556099109 | MGNX | MACROGENICS INC | $30.6M | 0.39% | 2,082,021 | Common | SOLE |
| 87990A106 | TNYA | TENAYA THERAPEUTICS INC | $30.1M | 0.39% | 5,755,050 | Common | SOLE |
| 23256X100 | — | CYBIN INC | $24.0M | 0.31% | 58,139,535 | Common | SOLE |
| 02157Q109 | ANRO | ALTO NEUROSCIENCE INC | $21.3M | 0.27% | 1,385,491 | Common | SOLE |
| 15713L109 | CRVO | CERVOMED INC | $20.1M | 0.26% | 861,573 | Common | SOLE |
| 92243A200 | VXRT | VAXART INC | $20.0M | 0.26% | 15,384,615 | Common | SOLE |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC-ADR | $19.9M | 0.26% | 800,000 | Common | SOLE |
| 30233G209 | EYPT | EYEPOINT PHARMACEUTICALS INC | $19.4M | 0.25% | 938,591 | Common | SOLE |
| 88427A107 | — | THIRD HARMONIC BIO INC | $19.2M | 0.25% | 2,033,056 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $19.1M | 0.24% | 1,281,000 | Common | SOLE |
| 81749D107 | SERA | SERA PROGNOSTICS INC-A | $18.4M | 0.24% | 2,024,221 | Common | SOLE |
| 59102M104 | MGX | METAGENOMI INC | $18.4M | 0.24% | 1,744,415 | Common | SOLE |
| N44445109 | IMTX | IMMATICS NV | $18.4M | 0.24% | 1,750,000 | Common | SOLE |
| 037326105 | ANTX | AN2 THERAPEUTICS INC | $18.0M | 0.23% | 5,551,295 | Common | SOLE |
| 75915K309 | RGLS | REGULUS THERAPEUTICS INC | $18.0M | 0.23% | 6,250,000 | Common | SOLE |
| 09203E105 | BDTX | BLACK DIAMOND THERAPEUTICS I | $17.9M | 0.23% | 3,525,754 | Common | SOLE |
| 007002108 | TORCEUR | ADICET BIO INC | $17.7M | 0.23% | 7,541,000 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $17.4M | 0.22% | 421,348 | Common | SOLE |
| 52886X107 | LXEO | LEXEO THERAPEUTICS INC | $10.4M | 0.13% | 660,938 | Common | SOLE |
| 16934W106 | CMRXEUR | CHIMERIX INC | $9.3M | 0.12% | 8,800,000 | Common | SOLE |
| 449585108 | 1K0 | IGM BIOSCIENCES INC | $9.0M | 0.12% | 937,500 | Common | SOLE |
| 20451W101 | CMPS | COMPASS PATHWAYS PLC | $6.6M | 0.08% | 791,359 | Common | SOLE |
| N2451R105 | CVAC | CUREVAC NV | $6.0M | 0.08% | 1,965,707 | Common | SOLE |
| 90466Y103 | — | UNICYCIVE THERAPEUTICS INC | $4.8M | 0.06% | 3,470,688 | Common | SOLE |
| N62509117 | NAMSW | NEWAMSTERDAM PHARMA CO NV-27 | $3.7M | 0.05% | 333,333 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.